Company intelligence / Profile preview

Cayman Chemical

Ann Arbor, Michigan, United Statescaymanchem.com ↗

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

Cayman Chemical provides over 15,000 life science research products including small molecules (>12k), assay kits (>3k), antibodies and recombinant proteins. The company has deep expertise in lipid chemistry—especially eicosanoids/prostaglandins—and supplies both research-use-only reagents globally as well as select clinical APIs such as Alprostadil. Its subsidiary Cayman Pharma s.r.o. manufactures pharmaceutical-grade prostaglandins for human/veterinary medicine under GMP standards.

Therapeutic areas: Men's HealthEndocrinologyOtherCardiovascularOphthalmology
Modalities: Small moleculesAssay kitsAntibodiesRecombinant proteinsAPIs (Active Pharmaceutical Ingredients)
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Cayman Chemical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cayman Chemical.

Explore the full profile